Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)

Fei Wang; Li Yang; Qun Gao; Lan Huang; Liping Wang; Jing Wang; Shengdian Wang; Bin Zhang; Yi Zhang

doi:10.1007/s00262-021-03023-1

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)

Fei Wang, Li Yang, Qun Gao, Lan Huang, Liping Wang, Jing Wang, Shengdian Wang, Bin Zhang, Yi Zhang^*

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The paper “CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (PMID: 25944005)” was published in Cancer Immunol Immunother at August 2015 online. After carefully re-checking the original files, we noticed that two issues should be explained and corrected as below.

Original language	English (US)
Pages (from-to)	3057-3059
Number of pages	3
Journal	Cancer Immunology, Immunotherapy
Volume	70
Issue number	10
DOIs	https://doi.org/10.1007/s00262-021-03023-1
State	Published - Oct 2021

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00262-021-03023-1

Cite this

Wang, F., Yang, L., Gao, Q., Huang, L., Wang, L., Wang, J., Wang, S., Zhang, B., & Zhang, Y. (2021). Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9). Cancer Immunology, Immunotherapy, 70(10), 3057-3059. https://doi.org/10.1007/s00262-021-03023-1

@article{579fb848f106418c94c91831a6c4a1df,

title = "Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)",

abstract = "The paper “CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (PMID: 25944005)” was published in Cancer Immunol Immunother at August 2015 online. After carefully re-checking the original files, we noticed that two issues should be explained and corrected as below.",

author = "Fei Wang and Li Yang and Qun Gao and Lan Huang and Liping Wang and Jing Wang and Shengdian Wang and Bin Zhang and Yi Zhang",

note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature.",

year = "2021",

month = oct,

doi = "10.1007/s00262-021-03023-1",

language = "English (US)",

volume = "70",

pages = "3057--3059",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "10",

}

Wang, F, Yang, L, Gao, Q, Huang, L, Wang, L, Wang, J, Wang, S, Zhang, B & Zhang, Y 2021, 'Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)', Cancer Immunology, Immunotherapy, vol. 70, no. 10, pp. 3057-3059. https://doi.org/10.1007/s00262-021-03023-1

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9). / Wang, Fei; Yang, Li; Gao, Qun et al.
In: Cancer Immunology, Immunotherapy, Vol. 70, No. 10, 10.2021, p. 3057-3059.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Correction to

T2 - CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)

AU - Wang, Fei

AU - Yang, Li

AU - Gao, Qun

AU - Huang, Lan

AU - Wang, Liping

AU - Wang, Jing

AU - Wang, Shengdian

AU - Zhang, Bin

AU - Zhang, Yi

PY - 2021/10

Y1 - 2021/10

N2 - The paper “CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (PMID: 25944005)” was published in Cancer Immunol Immunother at August 2015 online. After carefully re-checking the original files, we noticed that two issues should be explained and corrected as below.

AB - The paper “CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (PMID: 25944005)” was published in Cancer Immunol Immunother at August 2015 online. After carefully re-checking the original files, we noticed that two issues should be explained and corrected as below.

UR - http://www.scopus.com/inward/record.url?scp=85111733819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111733819&partnerID=8YFLogxK

U2 - 10.1007/s00262-021-03023-1

DO - 10.1007/s00262-021-03023-1

M3 - Comment/debate

C2 - 34347147

AN - SCOPUS:85111733819

SN - 0340-7004

VL - 70

SP - 3057

EP - 3059

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

IS - 10

ER -

Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this